title: [Scintigraphy of lymphomatous masses using 99mTc-MIBI].
abstract: Tc 99m sestamibi imaging is used in nuclear oncology, cardiology, but its role in detecting lymphomas has not been widely investigated. During 1998-2001 at the Department of Nuclear medicine, Kaunas University Hospital 68 patients with lymphomas (50 patients with Hodgkins disease (HD), 18 with non-Hodgkins (NHL)) underwent Tc 99m MIBI whole-body imaging. Of the 47 lymphoma lesions showed abnormal MIBI uptake. The accuracy of MIBI scintigraphy in patients with Hodgkins disease was lower (78%) compared to that of patients with non-Hodgkins lymphomas (94%). However, this difference was not related to tumor type, but to lesion size. Tumor size was significantly (p = 0.01) higher in lesions NHL with increased MIBI uptake (3.9 +/- 2.5 cm) compared with those with no uptake (1.5 +/- 0.5 cm).
authors.affiliation: Kauno medicinos universiteto Radiologijos klinika, Eiveniu 2, 3007 Kaunas. dobro@takas.lt
authors.forename: Laima
authors.initials: L
authors.lastname: Dobrovolskiene
authors.forename: Nemira
authors.initials: N
authors.lastname: Jurkiene
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000000981:diagnostic imaging; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis / Q000000981:diagnostic imaging*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000000981:diagnostic imaging; D008279:Magnetic Resonance Imaging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi